Pacific Biosciences Of California | PACB - Pre Tax Profit


Pacific Biosciences Of California reported $-40.17M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Agilent USD 364M 78M Dec/2025
Bruker USD 117M 95.1M Jun/2026
Danaher USD 1.08B 157M Jun/2026
General Electric Aerospace USD 2.2B 654M Mar/2026
Illumina USD 260M 103M Jun/2026
Myriad Genetics USD 4.6M 3.4M Dec/2025
Pacific Biosciences Of California USD -40.17M 2.55M Dec/2025
Quidel USD -79.5M 32.9M Mar/2026
Revvity USD 187.24M 137.25M Jun/2026
Roche Holding CHF 11.17B 6.38B Jun/2026
Standard Biotools USD -14.62M 7.42M Mar/2026
Thermo Fisher Scientific USD 1.73B 389M Mar/2026
Waters USD -88M 352.18M Mar/2026